These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324 [TBL] [Abstract][Full Text] [Related]
6. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention. Cathcart MC; Lysaght J; Pidgeon GP Cancer Metastasis Rev; 2011 Dec; 30(3-4):363-85. PubMed ID: 22134655 [TBL] [Abstract][Full Text] [Related]
7. The clinical utility of the local inflammatory response in colorectal cancer. Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145 [TBL] [Abstract][Full Text] [Related]
8. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis. Ribatti D Immunol Lett; 2013 May; 152(2):83-8. PubMed ID: 23685256 [TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and the immune response as targets for the prevention and treatment of colorectal cancer (review). Sharma RA; Dalgleish AG; Steward WP; O'Byrne KJ Oncol Rep; 2003; 10(5):1625-31. PubMed ID: 12883750 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy. Fantini MC; Becker C; Neurath MF Expert Rev Anticancer Ther; 2005 Aug; 5(4):681-94. PubMed ID: 16111468 [TBL] [Abstract][Full Text] [Related]
11. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Liu J; Duan Y; Cheng X; Chen X; Xie W; Long H; Lin Z; Zhu B Biochem Biophys Res Commun; 2011 Apr; 407(2):348-54. PubMed ID: 21396350 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Chaux P; Moutet M; Faivre J; Martin F; Martin M Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792 [TBL] [Abstract][Full Text] [Related]
14. Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Guthrie GJ; Roxburgh CS; Horgan PG; McMillan DC Cancer Treat Rev; 2013 Feb; 39(1):89-96. PubMed ID: 22858249 [TBL] [Abstract][Full Text] [Related]
16. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Roxburgh CS; McMillan DC Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823 [TBL] [Abstract][Full Text] [Related]
17. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. Kuang DM; Zhao Q; Wu Y; Peng C; Wang J; Xu Z; Yin XY; Zheng L J Hepatol; 2011 May; 54(5):948-55. PubMed ID: 21145847 [TBL] [Abstract][Full Text] [Related]
18. Inflammation and cancer: the role of the immune response and angiogenesis. Dalgleish AG; O'Byrne K Cancer Treat Res; 2006; 130():1-38. PubMed ID: 16610701 [TBL] [Abstract][Full Text] [Related]